|
2013 |
2014 |
2015 |
2016 |
2017 |
Overall |
|
Govt |
1.17 |
0.15 |
1.62 |
1.09 |
0.72 |
0.95 |
Generic |
|
|
0.44 |
1.35 |
|
|
0.89 |
Indication |
|
1.33 |
|
0.95 |
|
0.74 |
1.01 |
Molecule |
Academia, NGOs |
1.36 |
0.91 |
1.23 |
0.83 |
0.81 |
1.03 |
Generic |
|
|
1.23 |
1.08 |
0.93 |
1.56 |
1.20 |
Indication |
|
0.99 |
|
0.81 |
0.50 |
0.90 |
0.80 |
Molecule |
Trades |
1.11 |
0.79 |
0.96 |
1.01 |
0.72 |
0.92 |
Generic |
|
0.65 |
1.19 |
1.44 |
1.03 |
0.75 |
1.01 |
Indication |
|
0.94 |
0.78 |
0.95 |
0.98 |
0.62 |
0.85 |
Molecule |
Companies |
0.96 |
0.59 |
0.76 |
1.11 |
0.59 |
0.80 |
Generic |
|
1.44 |
1.16 |
0.85 |
1.05 |
1.08 |
1.12 |
Indication |
|
0.93 |
0.78 |
0.66 |
1.85 |
0.82 |
1.01 |
Molecule |